Pharma giant GSK just made a $5.1 billion bet on a cancer drugmaker (GSK, TSRO)

Reuters via handout GlaxoSmithKline just agreed to acquire the cancer drugmaker Tesaro for $ 5.1 billion in a bid to bulk up its cancer pipeline.  Tesaro makes a drug called Zejula, which is used to treat ovarian cancer.  GSK has been working to refresh its research-and-development strategy — in July it made a $ 300 […]

Pharma giant GSK just made a $5.1 billion bet on a cancer drugmaker (GSK, TSRO)

Reuters via handout GlaxoSmithKline just agreed to acquire the cancer drugmaker Tesaro for $ 5.1 billion in a bid to bulk up its cancer pipeline.  Tesaro makes a drug called Zejula, which is used to treat ovarian cancer.  GSK has been working to refresh its research-and-development strategy — in July it made a $ 300 […]